Cases & Deals

  • Home
  • Practices
  • Bambusa Therapeutics develops global patent portfolios for bispecific antibodies to treat immunological and inflammatory disorders

Share

Bambusa Therapeutics develops global patent portfolios for bispecific antibodies to treat immunological and inflammatory disorders

October 2024

Client(s) Bambusa Therapeutics, Inc.

Jones Day represents Bambusa Therapeutics, Inc. in developing global patent portfolios related to various bispecific antibodies for the treatment of immunological and inflammatory (I&I) disorders.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.